Cleared Traditional

RM4 Control Unit (K211224) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211224 · Institut Georges Lopez · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2021
Decision
175d
Days
Class 2
Risk

K211224 is an FDA 510(k) clearance for the RM4 Control Unit. Classified as System, Perfusion, Kidney (product code KDN), Class II - Special Controls.

Submitted by Institut Georges Lopez (Lissieu, FR). The FDA issued a Cleared decision on October 15, 2021 after a review of 175 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5880 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Institut Georges Lopez devices

Submission Details

510(k) Number K211224 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2021
Decision Date October 15, 2021
Days to Decision 175 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d slower than avg
Panel avg: 130d · This submission: 175d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KDN System, Perfusion, Kidney
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5880
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KDN System, Perfusion, Kidney

All 20
Devices cleared under the same product code (KDN) and FDA review panel - the closest regulatory comparables to K211224.
Servator P Plus SALF Solution
K230193 · S.A.L.F. Spa · Sep 2023
BAROguard
K223874 · Paragonix Technologies · Aug 2023
KIDNEY ASSIST-transport
K211333 · Xvivo Perfusion AB · Jan 2022
Servator P SALF Solution with THAM
K202652 · S.A.L.F. Spa · Aug 2021
Cannula for Organ Perfusion
K203262 · Bridge TO Life, Ltd. · Jul 2021
SherpaPak Pediatric Liver Transport System
K201048 · Paragonix Technologies · Jul 2020